Author

T. Lindenstrom

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

I. Rosenkrands· 2 shared J. S. Woodworth· 2 shared R. Mortensen· 2 shared A.-K. Stein· 1 shared A.-s. Gallouët· 1 shared C. Aagaard· 1 shared C. Joly· 1 shared C. S. Lindestam Arlehamn· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

I. Rosenkrands

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates

J. S. Woodworth, V. Contreras, D. Christensen, T. Naninck, N. Kahlaoui, A.-s. Gallouët, S. Langlois, E. Burban, C. Joly, W. Gros, N. Bosquet, J. Morin, M. L. Olsen, I. Rosenkrands, A.-K. Stein, , R. Mortensen

This paper develops a novel liposomal adjuvant, CAF(R)10b, that induces robust Th1/Th17 memory and mucosal recall responses in non-human primates.

bioRxiv · Feb 23, 2023 · PreprintImmunology

A novel Mycobacterium tuberculosis-specific subunit vaccine provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin

J. S. Woodworth, H. Strand Clemmensen, H. Battey, K. Dijkman, T. Lindenstrom, R. Salvador Laureano, R. Taplitz, J. Morgan, C. Aagaard, I. Rosenkrands, C. S. Lindestam Arlehamn, P. Andersen, R. Mortensen

This study develops a Mycobacterium tuberculosis-specific subunit vaccine, H107, which when co-administered with BCG enhances immune responses and provides better protection than either vaccine alone.

bioRxiv · Mar 18, 2021Immunology